Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 43/72 ]
NASDAQ | Common Stock
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets.
The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis.
It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Apr 30, 24 | -0.33 Increased by +15.38% | -0.36 Increased by +8.33% |
| Mar 5, 24 | -0.23 Increased by +25.81% | -0.26 Increased by +11.54% |
| Nov 7, 23 | -0.22 Decreased by -10.00% | -0.30 Increased by +26.67% |
| Aug 8, 23 | -0.29 Decreased by -11.54% | -0.35 Increased by +17.14% |
| May 9, 23 | -0.39 Decreased by -30.00% | -0.35 Decreased by -11.43% |
| Mar 7, 23 | -0.31 Decreased by -158.33% | -0.26 Decreased by -19.23% |
| Nov 14, 22 | -0.20 Decreased by -5.26% | -0.22 Increased by +9.09% |
| Aug 9, 22 | -0.26 Increased by +3.70% | -0.27 Increased by +3.70% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 14.30 M Decreased by -9.50% | -7.09 M Decreased by -32.23% | Decreased by -49.61% Decreased by -46.11% |
| Jun 30, 23 | 12.09 M Increased by +8.90% | -9.35 M Decreased by -19.38% | Decreased by -77.28% Decreased by -9.62% |
| Mar 31, 23 | 9.49 M Increased by +14.22% | -10.86 M Decreased by -16.68% | Decreased by -114.49% Decreased by -2.16% |
| Dec 31, 22 | 11.64 M Decreased by -26.50% | -9.24 M Decreased by -166.78% | Decreased by -79.40% Decreased by -262.97% |
| Sep 30, 22 | 15.80 M Increased by +25.92% | -5.36 M Decreased by -3.45% | Decreased by -33.96% Increased by +17.84% |
| Jun 30, 22 | 11.11 M Increased by +34.18% | -7.83 M Decreased by -5.46% | Decreased by -70.49% Increased by +21.41% |
| Mar 31, 22 | 8.31 M Increased by +49.85% | -9.31 M Decreased by -52.73% | Decreased by -112.08% Decreased by -1.93% |
| Dec 31, 21 | 15.84 M Increased by +177.09% | -3.46 M Increased by +66.12% | Decreased by -21.87% Increased by +87.77% |